CVS Health Files 8-K: Corporate Details Updated
Ticker: CVS · Form: 8-K · Filed: May 9, 2024 · CIK: 64803
Sentiment: neutral
Topics: corporate-filing, 8-K, regulatory-update
Related Tickers: CVS
TL;DR
CVS Health filed an 8-K updating corporate info. Nothing major, just housekeeping.
AI Summary
CVS Health Corporation filed an 8-K on May 9, 2024, reporting other events and financial statements. The filing details the company's principal executive offices located at One CVS Drive, Woonsocket, Rhode Island, 02895, and its IRS Employer Identification No. 05-0494040. The report confirms the company's incorporation in Delaware and its fiscal year end of December 31.
Why It Matters
This filing serves as an official update to CVS Health's corporate information, including its principal executive offices and tax identification number, which are crucial for regulatory and investor reference.
Risk Assessment
Risk Level: low — The filing is routine and primarily contains corporate information updates, not material events or financial performance changes.
Key Players & Entities
- CVS HEALTH Corp (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-01011 (identifier) — Commission File Number
- 05-0494040 (identifier) — IRS Employer Identification No.
- One CVS Drive, Woonsocket, Rhode Island 02895 (address) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for CVS Health Corporation?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits', and to update corporate information such as the principal executive offices.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 9, 2024.
In which state is CVS Health Corporation incorporated?
CVS Health Corporation is incorporated in Delaware.
What is the address of CVS Health's principal executive offices?
The address of CVS Health's principal executive offices is One CVS Drive, Woonsocket, Rhode Island 02895.
What is the IRS Employer Identification Number for CVS Health Corporation?
The IRS Employer Identification Number for CVS Health Corporation is 05-0494040.
Filing Stats: 711 words · 3 min read · ~2 pages · Grade level 8.4 · Accepted 2024-05-09 16:19:18
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
- $1,000,000,000 — ration (the "Company"), issued and sold $1,000,000,000 aggregate principal amount of the Compa
- $1,250,000,000 — nior Notes due 2031 (the "2031 Notes"), $1,250,000,000 aggregate principal amount of the Compa
- $750,000,000 — nior Notes due 2034 (the "2034 Notes"), $750,000,000 aggregate principal amount of the Compa
Filing Documents
- d802416d8k.htm (8-K) — 30KB
- d802416dex41.htm (EX-4.1) — 47KB
- d802416dex42.htm (EX-4.2) — 47KB
- d802416dex43.htm (EX-4.3) — 47KB
- d802416dex44.htm (EX-4.4) — 47KB
- d802416dex45.htm (EX-4.5) — 47KB
- d802416dex51.htm (EX-5.1) — 20KB
- g802416dsp70.jpg (GRAPHIC) — 3KB
- g802416g0509101857252.jpg (GRAPHIC) — 2KB
- 0001193125-24-135296.txt ( ) — 484KB
- cvs-20240509.xsd (EX-101.SCH) — 3KB
- cvs-20240509_lab.xml (EX-101.LAB) — 17KB
- cvs-20240509_pre.xml (EX-101.PRE) — 11KB
- d802416d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . The exhibits to this Current Report on Form 8-K are as follows: INDEX TO EXHIBITS Exhibit Description 4.1 Form of the 2029 Note. 4.2 Form of the 2031 Note. 4.3 Form of the 2034 Note. 4.4 Form of the 2044 Note. 4.5 Form of the 2054 Note. 5.1 Opinion of Allen Overy Shearman Sterling US LLP. 23.1 Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: May 9, 2024 By: /s/ Thomas F. Cowhey Thomas F. Cowhey Executive Vice President and Chief Financial Officer